|
|
||||||||
Ludwig Institute for Cancer Research, St Mary's Branch, St Mary's Hospital Medical School, Norfolk Place, London W2 1PG, U.K.
The intact terminal protein genes (TP1 and TP2) of Epstein-Barr virus (EBV) are created upon infection by circularization of the linear viral genome at its terminal repeats. The structure of the 1.7 kb TP2 latent mRNA has been determined by cDNA analysis and Northern blotting, revealing its close relation to TP1 mRNA. The 1.7 kb transcript is expressed from a different promoter and has a different 5' exon from TP1 but is also spliced across the terminal repeats. The last eight exons are common to the TP1 and TP2 RNAs. The TP2 promoter is 3.3 kb downstream of the TP1 promoter and is part of a bidirectional latent EBV promoter region transcribing the TP2 and the latent membrane protein RNAs in opposite directions.
Keywords: EBV, transcription, latent cycle
Received 25 February 1989;
accepted 10 July 1989.
This article has been cited by other articles:
![]() |
M. Rovedo and R. Longnecker Epstein-Barr Virus Latent Membrane Protein 2B (LMP2B) Modulates LMP2A Activity J. Virol., January 1, 2007; 81(1): 84 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jimenez-Ramirez, A. J. Brooks, L. P. Forshell, K. Yakimchuk, B. Zhao, T. Z. Fulgham, and C. E. Sample Epstein-Barr Virus EBNA-3C Is Targeted to and Regulates Expression from the Bidirectional LMP-1/2B Promoter J. Virol., November 15, 2006; 80(22): 11200 - 11208. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Bell, K. Groves, G. L. Kelly, D. Croom-Carter, E. Hui, A. T. C. Chan, and A. B. Rickinson Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. J. Gen. Virol., October 1, 2006; 87(Pt 10): 2885 - 2890. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Brinkmann and T. F. Schulz Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae. J. Gen. Virol., May 1, 2006; 87(Pt 5): 1047 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Peng, S. C. Moses, J. Tan, E. Kremmer, and P. D. Ling The Epstein-Barr Virus EBNA-LP Protein Preferentially Coactivates EBNA2-Mediated Stimulation of Latent Membrane Proteins Expressed from the Viral Divergent Promoter J. Virol., April 1, 2005; 79(7): 4492 - 4505. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Schaadt, B. Baier, J. Mautner, G. W. Bornkamm, and B. Adler Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivation J. Gen. Virol., March 1, 2005; 86(3): 551 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Salamon, M. Takacs, D. Ujvari, J. Uhlig, H. Wolf, J. Minarovits, and H. H. Niller Protein-DNA Binding and CpG Methylation at Nucleotide Resolution of Latency-Associated Promoters Qp, Cp, and LMP1p of Epstein-Barr Virus J. Virol., March 15, 2001; 75(6): 2584 - 2596. [Abstract] [Full Text] |
||||
![]() |
P. Rivailler, C. Quink, and F. Wang Strong Selective Pressure for Evolution of an Epstein-Barr Virus LMP2B Homologue in the Rhesus Lymphocryptovirus J. Virol., October 1, 1999; 73(10): 8867 - 8872. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Speck, K. A. Kline, P. Cheresh, and R. Longnecker Epstein-Barr virus lacking latent membrane protein 2 immortalizes B cells with efficiency indistinguishable from that of wild-type virus J. Gen. Virol., August 1, 1999; 80(8): 2193 - 2203. [Abstract] [Full Text] |
||||
![]() |
A. A. T. P. Brink, M. B. H. J. Vervoort, J. M. Middeldorp, C. J. L. M. Meijer, and A. J. C. van den Brule Nucleic Acid Sequence-Based Amplification, a New Method for Analysis of Spliced and Unspliced Epstein-Barr Virus Latent Transcripts, and Its Comparison with Reverse Transcriptase PCR J. Clin. Microbiol., November 1, 1998; 36(11): 3164 - 3169. [Abstract] [Full Text] |
||||
![]() |
G. Niedobitek, E. Kremmer, H. Herbst, L. Whitehead, C.W. Dawson, E. Niedobitek, C. von Ostau, N. Rooney, F.A. Grasser, and L.S. Young Immunohistochemical Detection of the Epstein-Barr Virus-Encoded Latent Membrane Protein 2A in Hodgkin's Disease and Infectious Mononucleosis Blood, August 15, 1997; 90(4): 1664 - 1672. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |